Ballance David James 4
4 · PhaseBio Pharmaceuticals Inc · Filed Nov 23, 2020
Insider Transaction Report
Form 4
Ballance David James
VP, Research and Sci. Affairs
Transactions
- Award
Common Stock
2020-11-20$3.00/sh+919$2,757→ 8,519 total
Footnotes (1)
- [F1]These shares were acquired under the PhaseBio Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).